Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) FCF Margin (2018 - 2026)

TransMedics has reported FCF Margin over the past 8 years, most recently at 47.58% for Q4 2025.

  • For Q4 2025, FCF Margin fell 6238.0% year-over-year to 47.58%; the TTM value through Dec 2025 reached 31.56%, up 2097.0%, while the annual FY2025 figure was 31.56%, 2097.0% up from the prior year.
  • FCF Margin for Q4 2025 was 47.58% at TransMedics, up from 43.07% in the prior quarter.
  • Over five years, FCF Margin peaked at 109.96% in Q4 2024 and troughed at 173.99% in Q3 2021.
  • A 5-year average of 29.73% and a median of 27.97% in 2022 define the central range for FCF Margin.
  • On a YoY basis, FCF Margin climbed as much as 14095bps in 2021 and fell as far as -8847bps in 2021.
  • Year by year, FCF Margin stood at 87.85% in 2021, then surged by 46bps to 47.86% in 2022, then skyrocketed by 119bps to 9.33% in 2023, then surged by 1079bps to 109.96% in 2024, then plummeted by -57bps to 47.58% in 2025.
  • Business Quant data shows FCF Margin for TMDX at 47.58% in Q4 2025, 43.07% in Q3 2025, and 52.45% in Q2 2025.